Document
false--12-31Q2201900009270661492000106680000.01000.0010.001450000000450000000166387307166532889166387307164472913805660007528300048330009529000012932100001011610001245160000.0010.00150000005000000003524098000364997800054.462060000112189000 0000927066 2019-01-01 2019-06-30 0000927066 2019-07-31 0000927066 2018-01-01 2018-06-30 0000927066 2019-04-01 2019-06-30 0000927066 2018-04-01 2018-06-30 0000927066 2018-12-31 0000927066 2019-06-30 0000927066 us-gaap:SegmentContinuingOperationsMember 2019-01-01 2019-06-30 0000927066 us-gaap:SegmentDiscontinuedOperationsMember 2018-01-01 2018-06-30 0000927066 us-gaap:SegmentDiscontinuedOperationsMember 2019-01-01 2019-06-30 0000927066 us-gaap:SegmentContinuingOperationsMember 2018-01-01 2018-06-30 0000927066 2017-12-31 0000927066 2018-06-30 0000927066 us-gaap:RetainedEarningsMember 2018-04-01 2018-06-30 0000927066 us-gaap:AdditionalPaidInCapitalMember 2018-04-01 2018-06-30 0000927066 us-gaap:CommonStockMember 2018-03-31 0000927066 us-gaap:NoncontrollingInterestMember 2018-06-30 0000927066 us-gaap:TreasuryStockMember 2018-03-31 0000927066 us-gaap:ParentMember 2018-04-01 2018-06-30 0000927066 dva:TemporaryEquityRedeemableNoncontrollingInterestsMember 2018-04-01 2018-06-30 0000927066 us-gaap:NoncontrollingInterestMember 2018-04-01 2018-06-30 0000927066 us-gaap:ParentMember 2018-03-31 0000927066 us-gaap:StockAppreciationRightsSARSMember us-gaap:ParentMember 2018-04-01 2018-06-30 0000927066 us-gaap:RetainedEarningsMember 2018-03-31 0000927066 us-gaap:TreasuryStockMember 2018-04-01 2018-06-30 0000927066 us-gaap:RestrictedStockUnitsRSUMember us-gaap:CommonStockMember 2018-04-01 2018-06-30 0000927066 us-gaap:StockAppreciationRightsSARSMember us-gaap:CommonStockMember 2018-04-01 2018-06-30 0000927066 dva:TemporaryEquityRedeemableNoncontrollingInterestsMember 2018-03-31 0000927066 us-gaap:RestrictedStockUnitsRSUMember us-gaap:AdditionalPaidInCapitalMember 2018-04-01 2018-06-30 0000927066 us-gaap:StockAppreciationRightsSARSMember us-gaap:AdditionalPaidInCapitalMember 2018-04-01 2018-06-30 0000927066 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-03-31 0000927066 us-gaap:RestrictedStockUnitsRSUMember us-gaap:ParentMember 2018-04-01 2018-06-30 0000927066 us-gaap:TreasuryStockMember 2018-06-30 0000927066 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-04-01 2018-06-30 0000927066 us-gaap:RetainedEarningsMember 2018-06-30 0000927066 dva:TemporaryEquityRedeemableNoncontrollingInterestsMember 2018-06-30 0000927066 us-gaap:NoncontrollingInterestMember 2018-03-31 0000927066 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-06-30 0000927066 us-gaap:CommonStockMember 2018-06-30 0000927066 us-gaap:AdditionalPaidInCapitalMember 2018-03-31 0000927066 us-gaap:ParentMember 2018-06-30 0000927066 us-gaap:AdditionalPaidInCapitalMember 2018-06-30 0000927066 us-gaap:ParentMember 2018-01-01 2018-06-30 0000927066 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-06-30 0000927066 us-gaap:StockAppreciationRightsSARSMember us-gaap:CommonStockMember 2018-01-01 2018-06-30 0000927066 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-01-01 2018-06-30 0000927066 us-gaap:NoncontrollingInterestMember 2018-01-01 2018-06-30 0000927066 us-gaap:RetainedEarningsMember 2017-12-31 0000927066 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-12-31 0000927066 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0000927066 dva:TemporaryEquityRedeemableNoncontrollingInterestsMember 2018-01-01 2018-06-30 0000927066 us-gaap:TreasuryStockMember 2017-12-31 0000927066 us-gaap:StockAppreciationRightsSARSMember us-gaap:ParentMember 2018-01-01 2018-06-30 0000927066 us-gaap:TreasuryStockMember 2018-01-01 2018-06-30 0000927066 us-gaap:RestrictedStockUnitsRSUMember us-gaap:ParentMember 2018-01-01 2018-06-30 0000927066 dva:TemporaryEquityRedeemableNoncontrollingInterestsMember 2017-12-31 0000927066 us-gaap:RestrictedStockUnitsRSUMember us-gaap:CommonStockMember 2018-01-01 2018-06-30 0000927066 us-gaap:ParentMember 2017-12-31 0000927066 us-gaap:RetainedEarningsMember 2018-01-01 2018-06-30 0000927066 us-gaap:StockAppreciationRightsSARSMember us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-06-30 0000927066 us-gaap:CommonStockMember 2017-12-31 0000927066 us-gaap:RestrictedStockUnitsRSUMember us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-06-30 0000927066 us-gaap:NoncontrollingInterestMember 2017-12-31 0000927066 us-gaap:TreasuryStockMember 2019-03-31 0000927066 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-04-01 2019-06-30 0000927066 us-gaap:ParentMember 2019-06-30 0000927066 us-gaap:ParentMember 2019-04-01 2019-06-30 0000927066 us-gaap:ParentMember 2019-03-31 0000927066 us-gaap:NoncontrollingInterestMember 2019-04-01 2019-06-30 0000927066 us-gaap:AdditionalPaidInCapitalMember 2019-04-01 2019-06-30 0000927066 us-gaap:TreasuryStockMember 2019-06-30 0000927066 us-gaap:CommonStockMember 2019-03-31 0000927066 us-gaap:RetainedEarningsMember 2019-04-01 2019-06-30 0000927066 us-gaap:NoncontrollingInterestMember 2019-03-31 0000927066 us-gaap:CommonStockMember 2019-04-01 2019-06-30 0000927066 us-gaap:TreasuryStockMember 2019-04-01 2019-06-30 0000927066 dva:TemporaryEquityRedeemableNoncontrollingInterestsMember 2019-04-01 2019-06-30 0000927066 us-gaap:NoncontrollingInterestMember 2019-06-30 0000927066 us-gaap:StockAppreciationRightsSARSMember us-gaap:ParentMember 2019-04-01 2019-06-30 0000927066 dva:TemporaryEquityRedeemableNoncontrollingInterestsMember 2019-03-31 0000927066 us-gaap:StockAppreciationRightsSARSMember us-gaap:CommonStockMember 2019-04-01 2019-06-30 0000927066 dva:TemporaryEquityRedeemableNoncontrollingInterestsMember 2019-06-30 0000927066 us-gaap:RestrictedStockUnitsRSUMember us-gaap:CommonStockMember 2019-04-01 2019-06-30 0000927066 us-gaap:RestrictedStockUnitsRSUMember us-gaap:ParentMember 2019-04-01 2019-06-30 0000927066 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-30 0000927066 us-gaap:RetainedEarningsMember 2019-03-31 0000927066 us-gaap:RestrictedStockUnitsRSUMember us-gaap:AdditionalPaidInCapitalMember 2019-04-01 2019-06-30 0000927066 us-gaap:RetainedEarningsMember 2019-06-30 0000927066 us-gaap:CommonStockMember 2019-06-30 0000927066 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0000927066 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-31 0000927066 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0000927066 us-gaap:ParentMember 2019-01-01 2019-06-30 0000927066 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-06-30 0000927066 us-gaap:RetainedEarningsMember 2018-12-31 0000927066 us-gaap:NoncontrollingInterestMember 2019-01-01 2019-06-30 0000927066 us-gaap:RestrictedStockUnitsRSUMember us-gaap:CommonStockMember 2019-01-01 2019-06-30 0000927066 dva:TemporaryEquityRedeemableNoncontrollingInterestsMember 2019-01-01 2019-06-30 0000927066 us-gaap:RetainedEarningsMember 2019-01-01 2019-06-30 0000927066 us-gaap:RestrictedStockUnitsRSUMember us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-06-30 0000927066 us-gaap:TreasuryStockMember 2019-01-01 2019-06-30 0000927066 us-gaap:ParentMember 2018-12-31 0000927066 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0000927066 dva:TemporaryEquityRedeemableNoncontrollingInterestsMember 2018-12-31 0000927066 us-gaap:NoncontrollingInterestMember 2018-12-31 0000927066 us-gaap:TreasuryStockMember 2018-12-31 0000927066 us-gaap:CommonStockMember 2019-01-01 2019-06-30 0000927066 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0000927066 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-06-30 0000927066 us-gaap:CommonStockMember 2018-12-31 0000927066 us-gaap:RestrictedStockUnitsRSUMember us-gaap:ParentMember 2019-01-01 2019-06-30 0000927066 us-gaap:StockAppreciationRightsSARSMember us-gaap:CommonStockMember 2019-01-01 2019-06-30 0000927066 us-gaap:StockAppreciationRightsSARSMember us-gaap:ParentMember 2019-01-01 2019-06-30 0000927066 dva:MedicareandMedicareAdvantageMember 2018-01-01 2018-06-30 0000927066 dva:MedicaidandManagedMedicaidMember 2019-01-01 2019-06-30 0000927066 dva:CommercialPayorsMember 2019-01-01 2019-06-30 0000927066 dva:MedicareandMedicareAdvantageMember dva:USDialysisAndRelatedLabServicesMember 2018-01-01 2018-06-30 0000927066 dva:MedicareandMedicareAdvantageMember 2019-01-01 2019-06-30 0000927066 dva:OtherSourcesofRevenueMember dva:USDialysisAndRelatedLabServicesMember 2018-01-01 2018-06-30 0000927066 dva:MedicaidandManagedMedicaidMember us-gaap:AllOtherSegmentsMember 2019-01-01 2019-06-30 0000927066 dva:MedicaidandManagedMedicaidMember dva:USDialysisAndRelatedLabServicesMember 2019-01-01 2019-06-30 0000927066 dva:OtherGovernmentPayorsMember dva:USDialysisAndRelatedLabServicesMember 2019-01-01 2019-06-30 0000927066 dva:OtherSourcesofRevenueMember dva:USDialysisAndRelatedLabServicesMember 2019-01-01 2019-06-30 0000927066 dva:MedicareandMedicareAdvantageMember us-gaap:AllOtherSegmentsMember 2019-01-01 2019-06-30 0000927066 us-gaap:IntersegmentEliminationMember 2018-01-01 2018-06-30 0000927066 dva:CommercialPayorsMember dva:USDialysisAndRelatedLabServicesMember 2018-01-01 2018-06-30 0000927066 dva:MedicaidandManagedMedicaidMember 2018-01-01 2018-06-30 0000927066 dva:OtherGovernmentPayorsMember dva:USDialysisAndRelatedLabServicesMember 2018-01-01 2018-06-30 0000927066 dva:OtherSourcesofRevenueMember 2019-01-01 2019-06-30 0000927066 dva:CommercialPayorsMember 2018-01-01 2018-06-30 0000927066 us-gaap:AllOtherSegmentsMember 2019-01-01 2019-06-30 0000927066 dva:OtherGovernmentPayorsMember 2019-01-01 2019-06-30 0000927066 us-gaap:IntersegmentEliminationMember dva:USDialysisAndRelatedLabServicesMember 2018-01-01 2018-06-30 0000927066 dva:MedicareandMedicareAdvantageMember dva:USDialysisAndRelatedLabServicesMember 2019-01-01 2019-06-30 0000927066 dva:MedicaidandManagedMedicaidMember dva:USDialysisAndRelatedLabServicesMember 2018-01-01 2018-06-30 0000927066 dva:CommercialPayorsMember us-gaap:AllOtherSegmentsMember 2019-01-01 2019-06-30 0000927066 dva:USDialysisAndRelatedLabServicesMember 2018-01-01 2018-06-30 0000927066 dva:CommercialPayorsMember us-gaap:AllOtherSegmentsMember 2018-01-01 2018-06-30 0000927066 dva:USDialysisAndRelatedLabServicesMember 2019-01-01 2019-06-30 0000927066 us-gaap:IntersegmentEliminationMember 2019-01-01 2019-06-30 0000927066 dva:OtherSourcesofRevenueMember 2018-01-01 2018-06-30 0000927066 dva:OtherGovernmentPayorsMember 2018-01-01 2018-06-30 0000927066 dva:MedicareandMedicareAdvantageMember us-gaap:AllOtherSegmentsMember 2018-01-01 2018-06-30 0000927066 dva:MedicaidandManagedMedicaidMember us-gaap:AllOtherSegmentsMember 2018-01-01 2018-06-30 0000927066 dva:CommercialPayorsMember dva:USDialysisAndRelatedLabServicesMember 2019-01-01 2019-06-30 0000927066 dva:OtherSourcesofRevenueMember us-gaap:AllOtherSegmentsMember 2019-01-01 2019-06-30 0000927066 dva:OtherSourcesofRevenueMember us-gaap:AllOtherSegmentsMember 2018-01-01 2018-06-30 0000927066 us-gaap:IntersegmentEliminationMember us-gaap:AllOtherSegmentsMember 2019-01-01 2019-06-30 0000927066 us-gaap:AllOtherSegmentsMember 2018-01-01 2018-06-30 0000927066 us-gaap:IntersegmentEliminationMember dva:USDialysisAndRelatedLabServicesMember 2019-01-01 2019-06-30 0000927066 dva:OtherGovernmentPayorsMember us-gaap:AllOtherSegmentsMember 2019-01-01 2019-06-30 0000927066 dva:OtherGovernmentPayorsMember us-gaap:AllOtherSegmentsMember 2018-01-01 2018-06-30 0000927066 us-gaap:IntersegmentEliminationMember us-gaap:AllOtherSegmentsMember 2018-01-01 2018-06-30 0000927066 us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2019-01-01 2019-06-30 0000927066 us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2018-04-01 2018-06-30 0000927066 us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2018-01-01 2018-06-30 0000927066 us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2019-04-01 2019-06-30 0000927066 2019-03-31 0000927066 us-gaap:IntersegmentEliminationMember us-gaap:AllOtherSegmentsMember 2018-04-01 2018-06-30 0000927066 dva:OtherSourcesofRevenueMember dva:USDialysisAndRelatedLabServicesMember 2018-04-01 2018-06-30 0000927066 us-gaap:IntersegmentEliminationMember dva:USDialysisAndRelatedLabServicesMember 2018-04-01 2018-06-30 0000927066 dva:MedicareandMedicareAdvantageMember 2018-04-01 2018-06-30 0000927066 us-gaap:AllOtherSegmentsMember 2018-04-01 2018-06-30 0000927066 dva:MedicareandMedicareAdvantageMember 2019-04-01 2019-06-30 0000927066 dva:CommercialPayorsMember dva:USDialysisAndRelatedLabServicesMember 2019-04-01 2019-06-30 0000927066 dva:MedicaidandManagedMedicaidMember dva:USDialysisAndRelatedLabServicesMember 2019-04-01 2019-06-30 0000927066 dva:MedicaidandManagedMedicaidMember dva:USDialysisAndRelatedLabServicesMember 2018-04-01 2018-06-30 0000927066 dva:MedicaidandManagedMedicaidMember us-gaap:AllOtherSegmentsMember 2019-04-01 2019-06-30 0000927066 dva:MedicareandMedicareAdvantageMember dva:USDialysisAndRelatedLabServicesMember 2018-04-01 2018-06-30 0000927066 dva:CommercialPayorsMember us-gaap:AllOtherSegmentsMember 2018-04-01 2018-06-30 0000927066 dva:MedicaidandManagedMedicaidMember us-gaap:AllOtherSegmentsMember 2018-04-01 2018-06-30 0000927066 dva:MedicareandMedicareAdvantageMember us-gaap:AllOtherSegmentsMember 2019-04-01 2019-06-30 0000927066 dva:CommercialPayorsMember us-gaap:AllOtherSegmentsMember 2019-04-01 2019-06-30 0000927066 dva:MedicaidandManagedMedicaidMember 2019-04-01 2019-06-30 0000927066 dva:MedicareandMedicareAdvantageMember dva:USDialysisAndRelatedLabServicesMember 2019-04-01 2019-06-30 0000927066 dva:OtherSourcesofRevenueMember us-gaap:AllOtherSegmentsMember 2019-04-01 2019-06-30 0000927066 dva:OtherGovernmentPayorsMember 2019-04-01 2019-06-30 0000927066 dva:CommercialPayorsMember dva:USDialysisAndRelatedLabServicesMember 2018-04-01 2018-06-30 0000927066 us-gaap:IntersegmentEliminationMember us-gaap:AllOtherSegmentsMember 2019-04-01 2019-06-30 0000927066 us-gaap:IntersegmentEliminationMember 2018-04-01 2018-06-30 0000927066 dva:MedicareandMedicareAdvantageMember us-gaap:AllOtherSegmentsMember 2018-04-01 2018-06-30 0000927066 dva:OtherGovernmentPayorsMember dva:USDialysisAndRelatedLabServicesMember 2019-04-01 2019-06-30 0000927066 dva:OtherSourcesofRevenueMember dva:USDialysisAndRelatedLabServicesMember 2019-04-01 2019-06-30 0000927066 us-gaap:AllOtherSegmentsMember 2019-04-01 2019-06-30 0000927066 dva:OtherGovernmentPayorsMember dva:USDialysisAndRelatedLabServicesMember 2018-04-01 2018-06-30 0000927066 dva:OtherGovernmentPayorsMember us-gaap:AllOtherSegmentsMember 2019-04-01 2019-06-30 0000927066 us-gaap:IntersegmentEliminationMember dva:USDialysisAndRelatedLabServicesMember 2019-04-01 2019-06-30 0000927066 dva:CommercialPayorsMember 2018-04-01 2018-06-30 0000927066 dva:OtherSourcesofRevenueMember us-gaap:AllOtherSegmentsMember 2018-04-01 2018-06-30 0000927066 dva:OtherSourcesofRevenueMember 2018-04-01 2018-06-30 0000927066 dva:USDialysisAndRelatedLabServicesMember 2019-04-01 2019-06-30 0000927066 dva:OtherGovernmentPayorsMember 2018-04-01 2018-06-30 0000927066 dva:USDialysisAndRelatedLabServicesMember 2018-04-01 2018-06-30 0000927066 dva:MedicaidandManagedMedicaidMember 2018-04-01 2018-06-30 0000927066 dva:OtherGovernmentPayorsMember us-gaap:AllOtherSegmentsMember 2018-04-01 2018-06-30 0000927066 dva:OtherSourcesofRevenueMember 2019-04-01 2019-06-30 0000927066 dva:CommercialPayorsMember 2019-04-01 2019-06-30 0000927066 us-gaap:IntersegmentEliminationMember 2019-04-01 2019-06-30 0000927066 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2019-01-01 2019-06-30 0000927066 dva:MutualFundsAndCommonStockMember 2019-01-01 2019-06-30 0000927066 dva:MutualFundsAndCommonStockMember 2018-01-01 2018-06-30 0000927066 dva:CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember 2018-12-31 0000927066 dva:CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember 2019-06-30 0000927066 us-gaap:OtherLongTermInvestmentsMember 2019-06-30 0000927066 us-gaap:OtherLongTermInvestmentsMember 2018-12-31 0000927066 us-gaap:ShortTermInvestmentsMember 2019-06-30 0000927066 dva:MutualFundsAndCommonStockMember 2018-12-31 0000927066 dva:MutualFundsAndCommonStockMember 2019-06-30 0000927066 us-gaap:ShortTermInvestmentsMember 2018-12-31 0000927066 srt:ScenarioForecastMember 2019-12-01 2019-12-01 0000927066 srt:ScenarioForecastMember 2019-08-01 2019-08-01 0000927066 srt:MaximumMember 2019-06-30 0000927066 srt:MinimumMember 2019-06-30 0000927066 dva:DeconsolidatedNoncontrollingEntityMember 2019-06-30 0000927066 us-gaap:EquitySecuritiesMember 2019-06-30 0000927066 us-gaap:EquitySecuritiesMember 2018-12-31 0000927066 us-gaap:OtherOwnershipInterestMember 2019-06-30 0000927066 dva:DeconsolidatedNoncontrollingEntityMember 2018-12-31 0000927066 us-gaap:OtherOwnershipInterestMember 2018-12-31 0000927066 dva:USDialysisAndRelatedLabServicesMember 2018-01-01 2018-12-31 0000927066 2018-01-01 2018-12-31 0000927066 dva:USDialysisAndRelatedLabServicesMember 2019-06-30 0000927066 us-gaap:AllOtherSegmentsMember 2018-01-01 2018-12-31 0000927066 us-gaap:AllOtherSegmentsMember 2019-06-30 0000927066 dva:USDialysisAndRelatedLabServicesMember 2017-12-31 0000927066 us-gaap:AllOtherSegmentsMember 2017-12-31 0000927066 dva:USDialysisAndRelatedLabServicesMember 2018-12-31 0000927066 us-gaap:AllOtherSegmentsMember 2018-12-31 0000927066 country:DE dva:KidneyCareMember 2019-01-01 2019-06-30 0000927066 country:BR dva:KidneyCareMember 2019-06-30 0000927066 country:DE dva:KidneyCareMember 2019-06-30 0000927066 country:BR dva:KidneyCareMember 2019-01-01 2019-06-30 0000927066 dva:OtherReportingUnitsMember 2019-01-01 2019-06-30 0000927066 dva:OtherReportingUnitsMember 2019-04-01 2019-06-30 0000927066 country:DE dva:OtherReportingUnitsMember 2018-01-01 2018-06-30 0000927066 dva:InterestRateCapAgreementsEffectiveJuneTwentyNineTwoThousandEighteenMember 2019-01-01 2019-06-30 0000927066 dva:InterestRateCapAgreementsEffectiveJuneTwentyNineTwoThousandEighteenMember 2018-12-31 0000927066 us-gaap:InterestRateCapMember us-gaap:CashFlowHedgingMember dva:DebtExpenseMember 2019-01-01 2019-06-30 0000927066 srt:MaximumMember dva:TermLoanFacilityMember dva:InterestRateCapOneMember 2019-06-30 0000927066 dva:InterestRateCapAgreementsEffectiveJuneTwentyNineTwoThousandEighteenMember 2019-06-30 0000927066 srt:MaximumMember dva:TermLoanFacilityMember dva:InterestRateCapOneMember 2019-01-01 2019-06-30 0000927066 us-gaap:CashFlowHedgingMember dva:IncomeTaxExpenseBenefitMember 2019-04-01 2019-06-30 0000927066 us-gaap:CashFlowHedgingMember 2019-01-01 2019-06-30 0000927066 us-gaap:CashFlowHedgingMember dva:IncomeTaxExpenseBenefitMember 2018-01-01 2018-06-30 0000927066 us-gaap:CashFlowHedgingMember 2018-01-01 2018-06-30 0000927066 us-gaap:CashFlowHedgingMember 2018-04-01 2018-06-30 0000927066 us-gaap:CashFlowHedgingMember 2019-04-01 2019-06-30 0000927066 us-gaap:InterestRateCapMember us-gaap:CashFlowHedgingMember dva:DebtExpenseMember 2018-04-01 2018-06-30 0000927066 us-gaap:CashFlowHedgingMember dva:IncomeTaxExpenseBenefitMember 2018-04-01 2018-06-30 0000927066 us-gaap:InterestRateCapMember us-gaap:CashFlowHedgingMember dva:DebtExpenseMember 2018-01-01 2018-06-30 0000927066 us-gaap:CashFlowHedgingMember dva:IncomeTaxExpenseBenefitMember 2019-01-01 2019-06-30 0000927066 us-gaap:InterestRateCapMember us-gaap:CashFlowHedgingMember dva:DebtExpenseMember 2019-04-01 2019-06-30 0000927066 dva:SeniorSecuredCreditFacilitiesMember 2018-12-31 0000927066 dva:TermLoanA2Member 2019-06-20 2019-06-20 0000927066 dva:SeniorSecuredCreditFacilitiesMember 2019-06-30 0000927066 dva:TermLoanAandA2Member 2019-04-01 2019-06-30 0000927066 us-gaap:SeniorNotesMember 2019-06-30 0000927066 us-gaap:DiscontinuedOperationsHeldforsaleMember dva:DaVitaMedicalGroupMember 2019-06-19 2019-06-19 0000927066 srt:ScenarioForecastMember dva:TermLoanAMember 2019-07-31 0000927066 us-gaap:RevolvingCreditFacilityMember 2019-04-01 2019-06-30 0000927066 dva:TermLoanAMember us-gaap:SubsequentEventMember 2019-07-03 2019-07-03 0000927066 srt:ScenarioForecastMember us-gaap:RevolvingCreditFacilityMember 2019-07-31 0000927066 dva:TermLoanBMember us-gaap:SubsequentEventMember 2019-07-31 0000927066 dva:TermLoanBMember 2019-04-01 2019-06-30 0000927066 dva:TermLoanASubjectToUncappedPortionOfVariabilityOfLIBORMember 2019-06-30 0000927066 dva:TermLoanBMember us-gaap:SubsequentEventMember 2019-07-03 2019-07-03 0000927066 srt:MinimumMember dva:TermLoanBMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-01-01 2019-06-30 0000927066 us-gaap:SubsequentEventMember 2019-07-03 2019-07-03 0000927066 srt:MaximumMember 2019-01-01 2019-06-30 0000927066 2019-05-06 2019-05-06 0000927066 dva:TermLoanAMember 2019-06-20 2019-06-20 0000927066 dva:TermLoanBMember 2019-06-30 0000927066 dva:TermLoanAMember 2019-06-30 0000927066 srt:ScenarioForecastMember dva:TermLoanBMember 2019-07-31 0000927066 us-gaap:RevolvingCreditFacilityMember 2019-06-30 0000927066 dva:TermLoanA2Member us-gaap:SubsequentEventMember 2019-07-03 2019-07-03 0000927066 us-gaap:SeniorNotesMember 2018-12-31 0000927066 dva:TermLoanA2Member 2019-01-01 2019-06-30 0000927066 dva:SeniorNotesFivePointZeroPercentDueTwentyTwentyFiveMember 2019-01-01 2019-06-30 0000927066 us-gaap:RevolvingCreditFacilityMember 2019-06-30 0000927066 dva:SeniorNotesFivePointSevenFivePercentageSeniorNotesMember 2019-06-30 0000927066 dva:TermLoanBMember 2018-12-31 0000927066 dva:FinanceLeaseMember 2019-06-30 0000927066 dva:TermLoanAMember 2019-01-01 2019-06-30 0000927066 dva:SeniorNotesFivePointSevenFivePercentageSeniorNotesMember 2019-01-01 2019-06-30 0000927066 dva:SeniorNotesFivePointOneTwoFivePercentDueTwentyTwentyFourMember 2019-01-01 2019-06-30 0000927066 dva:SeniorNotesFivePointOneTwoFivePercentDueTwentyTwentyFourMember 2019-06-30 0000927066 us-gaap:RevolvingCreditFacilityMember 2018-12-31 0000927066 dva:FinanceLeaseMember 2019-01-01 2019-06-30 0000927066 dva:SeniorNotesFivePointZeroPercentDueTwentyTwentyFiveMember 2019-06-30 0000927066 dva:TermLoanBMember 2019-01-01 2019-06-30 0000927066 dva:SeniorNotesFivePointSevenFivePercentageSeniorNotesMember 2018-12-31 0000927066 dva:TermLoanA2Member 2019-06-30 0000927066 us-gaap:NotesPayableOtherPayablesMember 2019-06-30 0000927066 us-gaap:RevolvingCreditFacilityMember 2019-01-01 2019-06-30 0000927066 dva:TermLoanAMember 2018-12-31 0000927066 dva:SeniorNotesFivePointZeroPercentDueTwentyTwentyFiveMember 2018-12-31 0000927066 dva:TermLoanA2Member 2018-12-31 0000927066 dva:SeniorNotesFivePointOneTwoFivePercentDueTwentyTwentyFourMember 2018-12-31 0000927066 us-gaap:NotesPayableOtherPayablesMember 2019-01-01 2019-06-30 0000927066 dva:TermLoanAandA2Member 2019-01-01 2019-06-30 0000927066 dva:USAttorneyPrescriptionDrugInvestigationMember dva:CashPaidForPortionPreviouslyRefundedMember 2017-12-01 2017-12-31 0000927066 dva:StockholderDerivativeLitigationMember 2017-08-15 2017-08-15 0000927066 dva:USAttorneyPrescriptionDrugInvestigationMember dva:IncrementalCashPortionMember 2017-12-01 2017-12-31 0000927066 dva:USAttorneyPrescriptionDrugInvestigationMember 2017-12-01 2017-12-31 0000927066 dva:CommitmentsToProvideOperatingCapitalMember 2019-06-30 0000927066 us-gaap:StockAppreciationRightsSARSMember 2019-01-01 2019-06-30 0000927066 us-gaap:RestrictedStockUnitsRSUMember 2019-01-01 2019-06-30 0000927066 us-gaap:GeneralAndAdministrativeExpenseMember 2018-01-01 2018-06-30 0000927066 us-gaap:GeneralAndAdministrativeExpenseMember 2019-01-01 2019-06-30 0000927066 us-gaap:SubsequentEventMember 2019-07-01 2019-07-17 0000927066 srt:MaximumMember us-gaap:SubsequentEventMember 2019-07-22 2019-08-16 0000927066 srt:MinimumMember us-gaap:SubsequentEventMember 2019-07-22 2019-08-16 0000927066 srt:MinimumMember srt:ScenarioForecastMember 2019-08-16 0000927066 us-gaap:SubsequentEventMember 2019-07-17 0000927066 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2018-04-01 2018-06-30 0000927066 us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2018-04-01 2018-06-30 0000927066 us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember 2018-01-01 2018-06-30 0000927066 us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2018-06-30 0000927066 us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2018-01-01 2018-06-30 0000927066 us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2018-04-01 0000927066 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2017-12-31 0000927066 us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2018-01-01 0000927066 us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2018-01-01 0000927066 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2018-01-01 2018-06-30 0000927066 us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember 2018-04-01 2018-06-30 0000927066 us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2018-01-01 2018-06-30 0000927066 us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember 2017-12-31 0000927066 us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember 2018-06-30 0000927066 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2018-04-01 0000927066 us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember 2018-03-31 0000927066 us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember 2018-04-01 0000927066 us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2018-06-30 0000927066 us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2017-12-31 0000927066 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2018-01-01 0000927066 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2018-06-30 0000927066 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2018-03-31 0000927066 us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember 2018-01-01 0000927066 us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2018-03-31 0000927066 us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2017-12-31 0000927066 us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2019-01-01 2019-06-30 0000927066 us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2019-04-01 2019-06-30 0000927066 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2019-04-01 2019-06-30 0000927066 us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember 2018-12-31 0000927066 us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember 2019-06-30 0000927066 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2019-01-01 2019-06-30 0000927066 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2018-12-31 0000927066 us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember 2019-04-01 2019-06-30 0000927066 us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember 2019-03-31 0000927066 us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember 2019-01-01 2019-06-30 0000927066 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2019-03-31 0000927066 us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2018-12-31 0000927066 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2019-06-30 0000927066 us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2019-03-31 0000927066 us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2019-06-30 0000927066 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2019-06-30 0000927066 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember dva:ForeignDialysisCentersMember 2019-01-01 2019-06-30 0000927066 us-gaap:OtherNoncurrentLiabilitiesMember 2019-06-30 0000927066 srt:MaximumMember dva:EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember dva:OtherCompaniesMember 2019-01-01 2019-06-30 0000927066 srt:MinimumMember dva:EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember dva:OtherCompaniesMember 2019-01-01 2019-06-30 0000927066 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember dva:USDialysisAndRelatedLabServicesMember 2019-01-01 2019-06-30 0000927066 dva:OtherAccruedLiabilitiesMember 2019-06-30 0000927066 dva:OtherCompaniesMember 2019-06-30 0000927066 us-gaap:NoncompeteAgreementsMember 2019-01-01 2019-06-30 0000927066 us-gaap:DiscontinuedOperationsHeldforsaleMember dva:DaVitaMedicalGroupMember 2018-04-01 2018-06-30 0000927066 us-gaap:DiscontinuedOperationsHeldforsaleMember dva:DaVitaMedicalGroupMember 2019-04-01 2019-06-30 0000927066 us-gaap:DiscontinuedOperationsHeldforsaleMember dva:DaVitaMedicalGroupMember 2018-01-01 2018-06-30 0000927066 us-gaap:DiscontinuedOperationsHeldforsaleMember dva:DaVitaMedicalGroupMember 2019-01-01 2019-06-30 0000927066 2019-06-19 2019-06-19 0000927066 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember dva:DaVitaMedicalGroupMember 2019-01-01 2019-06-18 0000927066 us-gaap:DiscontinuedOperationsHeldforsaleMember dva:DaVitaMedicalGroupMember 2017-12-05 2017-12-05 0000927066 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0000927066 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0000927066 us-gaap:InterestRateCapMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0000927066 us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0000927066 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0000927066 us-gaap:InterestRateCapMember us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0000927066 us-gaap:InterestRateCapMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0000927066 us-gaap:InterestRateCapMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0000927066 dva:DaVitaMedicalGroupMember 2018-12-31 0000927066 dva:DaVitaMedicalGroupMember 2019-06-30 0000927066 us-gaap:OperatingSegmentsMember dva:USDialysisAndRelatedLabServicesMember us-gaap:IntersubsegmentEliminationsMember 2019-04-01 2019-06-30 0000927066 us-gaap:OperatingSegmentsMember dva:USDialysisAndRelatedLabServicesMember 2019-01-01 2019-06-30 0000927066 us-gaap:OperatingSegmentsMember 2019-04-01 2019-06-30 0000927066 us-gaap:OperatingSegmentsMember dva:USDialysisAndRelatedLabServicesMember us-gaap:IntersubsegmentEliminationsMember 2018-01-01 2018-06-30 0000927066 us-gaap:OperatingSegmentsMember dva:USDialysisAndRelatedLabServicesMember dva:ExternalSourcesMember 2019-04-01 2019-06-30 0000927066 us-gaap:OperatingSegmentsMember us-gaap:AllOtherSegmentsMember 2018-04-01 2018-06-30 0000927066 us-gaap:OperatingSegmentsMember dva:USDialysisAndRelatedLabServicesMember 2019-04-01 2019-06-30 0000927066 us-gaap:OperatingSegmentsMember 2018-04-01 2018-06-30 0000927066 us-gaap:OperatingSegmentsMember dva:USDialysisAndRelatedLabServicesMember dva:ExternalSourcesMember 2019-01-01 2019-06-30 0000927066 us-gaap:OperatingSegmentsMember us-gaap:AllOtherSegmentsMember us-gaap:IntersubsegmentEliminationsMember 2018-01-01 2018-06-30 0000927066 us-gaap:OperatingSegmentsMember dva:USDialysisAndRelatedLabServicesMember us-gaap:IntersubsegmentEliminationsMember 2019-01-01 2019-06-30 0000927066 us-gaap:OperatingSegmentsMember dva:USDialysisAndRelatedLabServicesMember us-gaap:IntersubsegmentEliminationsMember 2018-04-01 2018-06-30 0000927066 us-gaap:OperatingSegmentsMember us-gaap:AllOtherSegmentsMember 2019-04-01 2019-06-30 0000927066 us-gaap:OperatingSegmentsMember us-gaap:AllOtherSegmentsMember 2019-01-01 2019-06-30 0000927066 us-gaap:OperatingSegmentsMember us-gaap:AllOtherSegmentsMember 2018-01-01 2018-06-30 0000927066 us-gaap:OperatingSegmentsMember 2018-01-01 2018-06-30 0000927066 us-gaap:OperatingSegmentsMember dva:USDialysisAndRelatedLabServicesMember dva:ExternalSourcesMember 2018-01-01 2018-06-30 0000927066 us-gaap:OperatingSegmentsMember 2019-01-01 2019-06-30 0000927066 us-gaap:OperatingSegmentsMember us-gaap:AllOtherSegmentsMember us-gaap:IntersubsegmentEliminationsMember 2019-01-01 2019-06-30 0000927066 us-gaap:OperatingSegmentsMember dva:USDialysisAndRelatedLabServicesMember 2018-04-01 2018-06-30 0000927066 us-gaap:OperatingSegmentsMember dva:USDialysisAndRelatedLabServicesMember 2018-01-01 2018-06-30 0000927066 us-gaap:OperatingSegmentsMember dva:USDialysisAndRelatedLabServicesMember dva:ExternalSourcesMember 2018-04-01 2018-06-30 0000927066 us-gaap:OperatingSegmentsMember us-gaap:AllOtherSegmentsMember us-gaap:IntersubsegmentEliminationsMember 2019-04-01 2019-06-30 0000927066 us-gaap:OperatingSegmentsMember us-gaap:AllOtherSegmentsMember us-gaap:IntersubsegmentEliminationsMember 2018-04-01 2018-06-30 0000927066 dva:DaVitaMedicalGroupMember 2019-01-01 2019-06-30 0000927066 dva:DaVitaMedicalGroupMember 2018-04-01 2018-06-30 0000927066 dva:DaVitaMedicalGroupMember 2019-04-01 2019-06-30 0000927066 dva:DaVitaMedicalGroupMember 2018-01-01 2018-06-30 0000927066 us-gaap:AccountingStandardsUpdate201602Member dva:LeaseLiabilitiesMember 2019-01-01 2019-01-01 0000927066 dva:CashFlowEffectMember us-gaap:AccountingStandardsUpdate201602Member 2019-01-01 2019-01-01 0000927066 us-gaap:AccountingStandardsUpdate201602Member dva:LeaseAssetsMember 2019-01-01 2019-01-01 0000927066 srt:GuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember 2018-04-01 2018-06-30 0000927066 srt:ParentCompanyMember srt:ReportableLegalEntitiesMember 2018-04-01 2018-06-30 0000927066 srt:ConsolidationEliminationsMember 2018-04-01 2018-06-30 0000927066 srt:NonGuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember 2018-04-01 2018-06-30 0000927066 srt:ParentCompanyMember srt:ReportableLegalEntitiesMember 2019-01-01 2019-06-30 0000927066 srt:ConsolidationEliminationsMember 2019-01-01 2019-06-30 0000927066 srt:GuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember 2019-01-01 2019-06-30 0000927066 srt:NonGuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember 2019-01-01 2019-06-30 0000927066 srt:ConsolidationEliminationsMember 2019-04-01 2019-06-30 0000927066 srt:GuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember 2019-04-01 2019-06-30 0000927066 srt:NonGuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember 2019-04-01 2019-06-30 0000927066 srt:ParentCompanyMember srt:ReportableLegalEntitiesMember 2019-04-01 2019-06-30 0000927066 srt:ConsolidationEliminationsMember us-gaap:SegmentContinuingOperationsMember 2019-01-01 2019-06-30 0000927066 srt:GuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember 2019-06-30 0000927066 srt:ConsolidationEliminationsMember us-gaap:SegmentDiscontinuedOperationsMember 2019-01-01 2019-06-30 0000927066 srt:GuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember us-gaap:SegmentDiscontinuedOperationsMember 2019-01-01 2019-06-30 0000927066 srt:NonGuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember us-gaap:SegmentContinuingOperationsMember 2019-01-01 2019-06-30 0000927066 srt:ConsolidationEliminationsMember 2018-12-31 0000927066 srt:NonGuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember 2018-12-31 0000927066 srt:ConsolidationEliminationsMember 2019-06-30 0000927066 srt:ParentCompanyMember srt:ReportableLegalEntitiesMember 2019-06-30 0000927066 srt:ParentCompanyMember srt:ReportableLegalEntitiesMember us-gaap:SegmentContinuingOperationsMember 2019-01-01 2019-06-30 0000927066 srt:ParentCompanyMember srt:ReportableLegalEntitiesMember us-gaap:SegmentDiscontinuedOperationsMember 2019-01-01 2019-06-30 0000927066 srt:GuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember us-gaap:SegmentContinuingOperationsMember 2019-01-01 2019-06-30 0000927066 srt:NonGuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember 2019-06-30 0000927066 srt:GuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember 2018-12-31 0000927066 srt:NonGuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember us-gaap:SegmentDiscontinuedOperationsMember 2019-01-01 2019-06-30 0000927066 srt:ParentCompanyMember srt:ReportableLegalEntitiesMember 2018-12-31 0000927066 srt:NonGuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember 2018-01-01 2018-06-30 0000927066 srt:ParentCompanyMember srt:ReportableLegalEntitiesMember 2018-01-01 2018-06-30 0000927066 srt:ConsolidationEliminationsMember 2018-01-01 2018-06-30 0000927066 srt:GuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember 2018-01-01 2018-06-30 0000927066 srt:ConsolidationEliminationsMember 2018-06-30 0000927066 srt:GuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember us-gaap:SegmentContinuingOperationsMember 2018-01-01 2018-06-30 0000927066 srt:GuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember us-gaap:SegmentDiscontinuedOperationsMember 2018-01-01 2018-06-30 0000927066 srt:GuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember 2017-12-31 0000927066 srt:NonGuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember 2017-12-31 0000927066 srt:GuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember 2018-06-30 0000927066 srt:NonGuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember 2018-06-30 0000927066 srt:NonGuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember us-gaap:SegmentDiscontinuedOperationsMember 2018-01-01 2018-06-30 0000927066 srt:ParentCompanyMember srt:ReportableLegalEntitiesMember us-gaap:SegmentContinuingOperationsMember 2018-01-01 2018-06-30 0000927066 srt:NonGuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember us-gaap:SegmentContinuingOperationsMember 2018-01-01 2018-06-30 0000927066 srt:ParentCompanyMember srt:ReportableLegalEntitiesMember us-gaap:SegmentDiscontinuedOperationsMember 2018-01-01 2018-06-30 0000927066 srt:ParentCompanyMember srt:ReportableLegalEntitiesMember 2018-06-30 0000927066 srt:ConsolidationEliminationsMember us-gaap:SegmentContinuingOperationsMember 2018-01-01 2018-06-30 0000927066 srt:ConsolidationEliminationsMember us-gaap:SegmentDiscontinuedOperationsMember 2018-01-01 2018-06-30 0000927066 srt:ParentCompanyMember srt:ReportableLegalEntitiesMember 2017-12-31 0000927066 srt:ConsolidationEliminationsMember 2017-12-31 0000927066 dva:PhysicianGroupOrganizationMember 2019-06-30 0000927066 dva:UnrestrictedSubsidiariesMember 2019-06-30 0000927066 dva:ParentCompanyAndRestrictedSubsidiariesMember 2019-06-30 0000927066 dva:PhysicianGroupOrganizationMember 2019-01-01 2019-06-30 0000927066 dva:ParentCompanyAndRestrictedSubsidiariesMember 2019-01-01 2019-06-30 0000927066 dva:UnrestrictedSubsidiariesMember 2019-01-01 2019-06-30 0000927066 dva:ParentCompanyAndRestrictedSubsidiariesMember us-gaap:SegmentDiscontinuedOperationsMember 2019-01-01 2019-06-30 0000927066 dva:ParentCompanyAndRestrictedSubsidiariesMember 2018-12-31 0000927066 dva:PhysicianGroupOrganizationMember us-gaap:SegmentContinuingOperationsMember 2019-01-01 2019-06-30 0000927066 dva:PhysicianGroupOrganizationMember us-gaap:SegmentDiscontinuedOperationsMember 2019-01-01 2019-06-30 0000927066 dva:ParentCompanyAndRestrictedSubsidiariesMember us-gaap:SegmentContinuingOperationsMember 2019-01-01 2019-06-30 0000927066 dva:PhysicianGroupOrganizationMember 2018-12-31 0000927066 dva:UnrestrictedSubsidiariesMember us-gaap:SegmentContinuingOperationsMember 2019-01-01 2019-06-30 0000927066 dva:UnrestrictedSubsidiariesMember us-gaap:SegmentDiscontinuedOperationsMember 2019-01-01 2019-06-30 0000927066 dva:UnrestrictedSubsidiariesMember 2018-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares dva:clinic xbrli:pure dva:segment



 
 
 
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
 
 
 
FORM 10-Q
 
 
 
 
 
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the Quarterly Period Ended June 30, 2019
or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ___________ to ___________
Commission File Number: 1-14106
 
 
 
 
 

http://api.tenkwizard.com/cgi/image?quest=1&rid=23&ipage=13038171&doc=12
DAVITA INC.
Delaware
 
51-0354549
(State of incorporation)
 
(I.R.S. Employer Identification No.)
2000 16th Street
Denver,
CO
80202
Telephone number (720631-2100
Securities registered pursuant to Section 12(b) of the Act:
Title of each class:
 
Trading symbol(s):
 
Name of each exchange on which registered:
Common Stock, $0.001 par value
 
DVA
 
NYSE
 
 
 
 
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☒    No  ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ☒    No  ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer", "accelerated filer", "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer
Accelerated filer
 
 
 
 
Non-accelerated filer
☐ 
Smaller reporting company
 
 
 
 
Emerging growth company
 
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act)    Yes      No  ☒
As of July 31, 2019, the number of shares of the Registrant’s common stock outstanding was approximately 160.3 million shares.
 
 
 
 
 




DAVITA INC.
INDEX

 
 
 
 
Page No.
 
 
PART I. FINANCIAL INFORMATION
 
 
 
 
 
 
 
Item 1.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Item 2.
 
 
Item 3.
 
 
Item 4.
 
 
 
 
 
 
 
 
 
PART II. OTHER INFORMATION
 
 
Item 1.
 
 
Item 1A.
 
 
Item 2.
 
 
Item 6.
 
 
 
 
 
 
Note: Items 3, 4 and 5 of Part II are omitted because they are not applicable.
 
 
 

i




DAVITA INC.
CONSOLIDATED STATEMENTS OF INCOME
(unaudited)
(dollars in thousands, except per share data)
 
Three months ended June 30,
 
Six months ended June 30,
 
2019
 
2018
 
2019
 
2018
Dialysis and related lab patient service revenues
$
2,734,065

 
$
2,718,403

 
$
5,369,217

 
$
5,309,477

Provision for uncollectible accounts
(10,249
)
 
(49,406
)
 
(15,712
)
 
(23,861
)
Net dialysis and related lab patient service revenues
2,723,816

 
2,668,997

 
5,353,505

 
5,285,616

Other revenues
118,889

 
217,956

 
232,312

 
450,781

Total revenues
2,842,705

 
2,886,953

 
5,585,817

 
5,736,397

Operating expenses and charges:
 

 
 

 
 

 
 

Patient care costs
1,957,753

 
2,069,089

 
3,922,688

 
4,104,674

General and administrative
275,338

 
264,094

 
526,151

 
530,623

Depreciation and amortization
152,242

 
147,079

 
300,770

 
289,878

Provision for uncollectible accounts

 
(2,100
)
 

 
(8,100
)
Equity investment income
(4,514
)
 
(9,795
)
 
(7,222
)
 
(9,950
)
Impairment of other assets

 
11,245

 

 
11,245

Goodwill impairment charges

 
3,106

 
41,037

 
3,106

Gain on changes in ownership interest, net

 
(33,957
)
 

 
(33,957
)
Total operating expenses and charges
2,380,819

 
2,448,761

 
4,783,424

 
4,887,519

Operating income
461,886

 
438,192

 
802,393

 
848,878

Debt expense
(131,666
)
 
(119,692
)
 
(263,185
)
 
(233,208
)
Debt prepayment charges
(12,160
)
 

 
(12,160
)
 

Other income, net
5,643

 
1,994

 
12,583

 
6,576

Income from continuing operations before income taxes
323,703

 
320,494

 
539,631

 
622,246

Income tax expense
75,938

 
83,868

 
132,684

 
154,605

Net income from continuing operations
247,765

 
236,626

 
406,947

 
467,641

Net income from discontinued operations, net of tax
79,392

 
69,696

 
109,697

 
63,910

Net income
327,157

 
306,322

 
516,644

 
531,551

Less: Net income attributable to noncontrolling interests
(53,606
)
 
(39,046
)
 
(93,804
)
 
(85,589
)
Net income attributable to DaVita Inc.
$
273,551

 
$
267,276

 
$
422,840

 
$
445,962

Earnings per share attributable to DaVita Inc.:
 

 
 

 
 

 
 

Basic net income from continuing operations per share
$
1.17

 
$
1.16

 
$
1.89

 
$
2.23

Basic net income per share
$
1.64

 
$
1.56

 
$
2.54

 
$
2.54

Diluted net income from continuing operations per share
$
1.16

 
$
1.15

 
$
1.89

 
$
2.19

Diluted net income per share
$
1.64

 
$
1.53

 
$
2.54

 
$
2.51

Weighted average shares for earnings per share:
 
 
 
 
 

 
 

Basic
166,346,041

 
171,617,238

 
166,366,886

 
175,267,270

Diluted
166,799,525

 
174,105,884

 
166,789,978

 
177,949,934

Amounts attributable to DaVita Inc.:
 
 
 
 
 
 
 
Net income from continuing operations
$
194,223

 
$
199,603

 
$
314,477

 
$
390,618

Net income from discontinued operations
79,328

 
67,673

 
108,363

 
55,344

Net income attributable to DaVita Inc.
$
273,551

 
$
267,276

 
$
422,840

 
$
445,962

 
See notes to condensed consolidated financial statements.

1



DAVITA INC.
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(unaudited)
(dollars in thousands)
 
 
Three months ended June 30,
 
Six months ended June 30,
 
2019
 
2018
 
2019
 
2018
Net income
$
327,157

 
$
306,322

 
$
516,644

 
$
531,551

Other comprehensive income, net of tax:
 

 
 

 
 

 
 

Unrealized (losses) gains on interest rate cap agreements:
 

 
 

 
 

 
 

Unrealized (losses) gains
(31
)
 
(268
)
 
(611
)
 
782

Reclassifications of net realized losses into net income
1,606

 
1,537

 
3,212

 
3,074

Unrealized gains (losses) on foreign currency translation:
 
 
 

 
 
 
 

Foreign currency translation adjustments
12,365

 
(50,529
)
 
(1,288
)
 
(30,648
)
Other comprehensive income (loss)
13,940

 
(49,260
)
 
1,313

 
(26,792
)
Total comprehensive income
341,097

 
257,062

 
517,957

 
504,759

Less: Comprehensive income attributable to noncontrolling interests
(53,606
)
 
(39,046
)
 
(93,804
)
 
(85,589
)
Comprehensive income attributable to DaVita Inc.
$
287,491

 
$
218,016

 
$
424,153

 
$
419,170

 See notes to condensed consolidated financial statements.


2



DAVITA INC.
CONSOLIDATED BALANCE SHEETS
(unaudited)
(dollars in thousands, except per share data)
 
June 30, 2019
 
December 31, 2018
ASSETS
 

 
 

Cash and cash equivalents
$
3,575,638

 
$
323,038

Restricted cash and equivalents
106,772

 
92,382

Short-term investments
5,213

 
2,935

Accounts receivable, net
2,010,801

 
1,858,608

Inventories
96,819

 
107,381

Other receivables
525,004

 
469,796

Income tax receivable
15,783

 
68,614

Prepaid and other current assets
54,599

 
111,840

Current assets held for sale, net

 
5,389,565

Total current assets
6,390,629

 
8,424,159

Property and equipment, net of accumulated depreciation of $3,649,978 and $3,524,098
3,405,315

 
3,393,669

Operating lease right-of-use assets
2,790,885

 

Intangible assets, net of accumulated amortization of $75,283 and $80,566
120,574

 
118,846

Equity method and other investments
225,677

 
224,611

Long-term investments
35,051

 
35,424

Other long-term assets
97,443

 
71,583

Goodwill
6,865,386

 
6,841,960

 
$
19,930,960

 
$
19,110,252

LIABILITIES AND EQUITY
 

 
 

Accounts payable
$
388,955

 
$
463,270

Other liabilities
726,011

 
595,850

Accrued compensation and benefits
628,022

 
658,913

Current portion of operating lease liabilities
372,625

 

Current portion of long-term debt
3,591,331

 
1,929,369

Current liabilities held for sale

 
1,243,759

Total current liabilities
5,706,944

 
4,891,161

Long-term operating lease liabilities
2,689,249

 

Long-term debt
5,377,798

 
8,172,847

Other long-term liabilities
134,605

 
450,669

Deferred income taxes
593,562

 
562,536

Total liabilities
14,502,158

 
14,077,213

Commitments and contingencies
 
 
 
Noncontrolling interests subject to put provisions
1,185,733

 
1,124,641

Equity:
 

 
 

Preferred stock ($0.001 par value, 5,000,000 shares authorized; none issued)

 

Common stock ($0.001 par value, 450,000,000 shares authorized; 166,532,889 and
166,387,307 shares issued and 164,472,913 and 166,387,307 shares outstanding, respectively)
167

 
166

Additional paid-in capital
989,021

 
995,006

Retained earnings
3,205,910

 
2,743,194

Treasury stock (2,059,976 and zero shares, respectively)
(112,189
)
 

Accumulated other comprehensive loss
(33,611
)
 
(34,924
)
Total DaVita Inc. shareholders' equity
4,049,298

 
3,703,442

Noncontrolling interests not subject to put provisions
193,771

 
204,956

Total equity
4,243,069

 
3,908,398

 
$
19,930,960

 
$
19,110,252

See notes to condensed consolidated financial statements.

3



DAVITA INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(unaudited)
(dollars in thousands)
 
Six months ended June 30,
 
2019
 
2018
Cash flows from operating activities:
 

 
 

Net income
$
516,644

 
$
531,551

Adjustments to reconcile net income to net cash provided by operating activities:
 
 
 

Depreciation and amortization
300,770

 
289,878

Impairment charges
41,037

 
14,351

Stock-based compensation expense
29,045

 
19,861

Deferred income taxes
60,706

 
56,882

Equity investment income (loss), net
2,631

 
(434
)
Loss (gain) on sales of business interests, net
23,022

 
(59,053
)
Other non-cash charges, net
25,857

 
44,337

Changes in operating assets and liabilities, net of effect of acquisitions and divestitures:
 
 
 
Accounts receivable
(288,437
)
 
(101,746
)
Inventories
11,542

 
71,632

Other receivables and other current assets
(5,142
)
 
(91,685
)
Other long-term assets
(410
)
 
3,454

Accounts payable
(68,887
)
 
35,228

Accrued compensation and benefits
(88,473
)
 
23,818

Other current liabilities
151,780

 
58,321

Income taxes
57,551

 
24,356

Other long-term liabilities
(18,121
)
 
3,824

Net cash provided by operating activities
751,115

 
924,575

Cash flows from investing activities:
 
 
 

Additions of property and equipment
(373,918
)
 
(473,977
)
Acquisitions
(65,970
)
 
(89,465
)
Proceeds from asset and business sales
3,851,381

 
116,241

Purchase of other debt and equity investments
(4,812
)
 
(4,195
)
Purchase of investments held-to-maturity
(3,322
)
 
(3,726
)
Proceeds from sale of other debt and equity investments
5,893

 
5,662

Proceeds from investments held-to-maturity

 
32,628

Purchase of equity investments
(6,715
)
 
(10,241
)
Distributions received on equity investments
155

 
3,009

Net cash provided by (used in) investing activities
3,402,692

 
(424,064
)
Cash flows from financing activities:
 
 
 
Borrowings
32,367,300

 
28,128,131

Payments on long-term debt and other financing costs
(33,531,409
)
 
(27,556,348
)
Purchase of treasury stock
(73,078
)
 
(805,179
)
Distributions to noncontrolling interests
(95,714
)
 
(94,006
)
Stock award exercises and other share issuances, net
2,107

 
3,132

Contributions from noncontrolling interests
31,281

 
31,569

Proceeds from sales of additional noncontrolling interest

 
15

Purchases of noncontrolling interests
(11,040
)
 
(13,223
)
Net cash used in financing activities
(1,310,553
)
 
(305,909
)
Effect of exchange rate changes on cash, cash equivalents and restricted cash
(77
)
 
(3,473
)
Net increase in cash, cash equivalents and restricted cash
2,843,177

 
191,129

Less: Net (decrease) increase in cash, cash equivalents and restricted cash from discontinued operations
(423,813
)
 
229,901

Net increase (decrease) in cash, cash equivalents and restricted cash from continuing operations
3,266,990

 
(38,772
)
Cash, cash equivalents and restricted cash of continuing operations at beginning of the year
415,420

 
518,920

Cash, cash equivalents and restricted cash of continuing operations at end of the period
$
3,682,410

 
$
480,148

See notes to condensed consolidated financial statements.

4



DAVITA INC.
CONSOLIDATED STATEMENTS OF EQUITY
(unaudited)
(dollars and shares in thousands)
 
Three months ended June 30, 2019
 
Non-
controlling
interests
subject to
put provisions
 
DaVita Inc. Shareholders’ Equity
 
Non-
controlling
interests not
subject to
put provisions
 
 
 
 
 
Common stock
 
Additional
paid-in
capital
 
Retained
earnings
 
Treasury stock
 
Accumulated
other
comprehensive
loss
 
 
 
 
 
Shares
 
Amount
 
 
 
Shares
 
Amount
 
 
Total
 
Balance at March 31, 2019
$
1,143,044

 
166,396

 
$
166

 
$
990,380

 
$
2,932,359

 

 
$

 
$
(47,551
)
 
$
3,875,354

 
$
211,319

Comprehensive income:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income
37,911

 
 
 
 
 
 
 
273,551

 
 
 
 
 
 
 
273,551

 
15,695

Other comprehensive loss
 
 
 
 
 
 
 
 
 
 
 
 
 
 
13,940

 
13,940

 
 
Stock purchase shares issued
 
 

 
 
 

 
 
 
 
 
 
 
 
 

 
 
Stock unit shares issued
 
 
137

 
1

 
(3,142
)
 
 
 
 
 
 
 
 
 
(3,141
)
 
 
Stock-settled SAR shares issued
 
 

 
 
 
 
 
 
 
 
 
 
 
 
 

 
 
Stock-settled stock-based
compensation expense
 
 
 
 
 
 
16,908

 
 
 
 
 
 
 
 
 
16,908

 
 
Changes in noncontrolling interest
from:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Distributions
(32,670
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(18,814
)
Contributions
9,353

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2,981

Acquisitions and divestitures
111

 
 
 
 
 

 
 
 
 
 
 
 
 
 

 
(1,991
)
Partial purchases
(281
)
 
 
 
 
 
13,140

 
 
 
 
 
 
 
 
 
13,140

 
(15,419
)
Fair value remeasurements
28,265

 
 
 
 
 
(28,265
)
 
 
 
 
 
 
 
 
 
(28,265
)
 
 
Purchase of treasury stock
 
 
 
 
 
 
 
 
 
 
(2,060
)
 
(112,189
)
 
 
 
(112,189
)
 
 
Balance at June 30, 2019
$
1,185,733

 
166,533

 
$
167

 
$
989,021

 
$
3,205,910

 
(2,060
)
 
$
(112,189
)
 
$
(33,611
)
 
$
4,049,298

 
$
193,771


 
Six months ended June 30, 2019
 
Non-
controlling
interests
subject to
put provisions
 
DaVita Inc. Shareholders’ Equity
 
Non-
controlling
interests not
subject to
put provisions
 
 
 
 
 
Common stock
 
Additional
paid-in
capital
 
Retained
earnings
 
Treasury stock
 
Accumulated
other
comprehensive
loss
 
 
 
 
 
Shares
 
Amount
 
 
 
Shares
 
Amount
 
 
Total
 
Balance at January 1, 2019
$
1,124,641

 
166,387

 
$
166

 
$
995,006

 
$
2,743,194

 

 
$

 
$
(34,924
)
 
$
3,703,442

 
$
204,956

Cumulative effect of change
in accounting principle
(38
)
 


 


 


 
39,876

 


 


 


 
39,876

 
(6
)
Comprehensive income:
 
 


 


 


 


 


 


 


 
 
 


Net income
63,300

 


 


 


 
422,840

 


 


 


 
422,840

 
30,504

Other comprehensive loss


 


 


 


 


 


 


 
1,313

 
1,313

 


Stock purchase shares issued


 

 


 

 


 


 


 


 

 


Stock unit shares issued


 
146

 
1

 
(3,246
)
 


 


 


 


 
(3,245
)
 


Stock-settled SAR shares issued


 

 


 


 


 


 


 


 

 


Stock-settled stock-based
compensation expense
 
 
 
 
 
 
28,999

 
 
 
 
 
 
 
 
 
28,999

 
 
Changes in noncontrolling interest
from:


 


 


 


 


 


 


 


 


 


Distributions
(60,235
)
 


 


 


 


 


 


 


 


 
(35,479
)
Contributions
15,768

 


 


 


 


 


 


 


 


 
15,513

Acquisitions and divestitures
1,873

 


 


 

 


 


 


 


 

 
(1,991
)
Partial purchases
(2,248
)
 


 


 
10,934

 


 


 


 


 
10,934

 
(19,726
)
Fair value remeasurements
42,672

 


 


 
(42,672
)
 


 


 


 


 
(42,672
)
 


Purchase of treasury stock
 
 
 
 
 
 
 
 
 
 
(2,060
)
 
(112,189
)
 
 
 
(112,189
)
 
 
Balance at June 30, 2019
$
1,185,733

 
166,533

 
$
167

 
$
989,021

 
$
3,205,910

 
(2,060
)
 
$
(112,189
)
 
$
(33,611
)
 
$
4,049,298

 
$
193,771

See notes to condensed consolidated financial statements.

5



DAVITA INC.
CONSOLIDATED STATEMENTS OF EQUITY - continued
(unaudited)
(dollars and shares in thousands)

 
Three months ended June 30, 2018
 
Non-
controlling
interests
subject to
put provisions
 
DaVita Inc. Shareholders’ Equity
 
Non-
controlling
interests not
subject to
put provisions
 
 
 
 
 
Common stock
 
Additional
paid-in
capital
 
Retained
earnings
 
Treasury stock
 
Accumulated
other
comprehensive
income
 
 
 
 
 
Shares
 
Amount
 
 
 
Shares
 
Amount
 
 
Total
 
Balance at March 31, 2018
$